Detailed price information for Genscript Biotech Corp (GNNSF) from The Globe and Mail including charting and trades.
The MarketWatch News Department was not involved in the creation of this content. Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in ...
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, ...
PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...
The MarketWatch News Department was not involved in the creation of this content. PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science ...
The average one-year price target for Genscript Biotech (OTCPK:GNNSF) has been revised to $3.32 / share. This is an increase of 16.00% from the prior estimate of $2.86 dated April 1, 2025. The price ...
GenScript Is a Leader in Gene Synthesis and a CRO, CDMO, and Biotech All Rolled Into One GenScript Biotech provides life science research services and products, and is well known for its gene ...
A deal between Shenzhen-based XTalPi and US firm DoveTree shows Chinese biotech AI capabilities are gaining recognition ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond "The conversations throughout the day reinforced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results